Geitmyrsveien 69 (map)
On the occasion of Olav Schreurs’ disputas, the opponents will give two guest lectures.
Preet Bano Singh will be presenting her trial lecture for the academic position of Associated Professor/Professor in Cariology and Gerodontology - "Dental considerations in patients with complicated medical history".
Aida Mulic will be presenting her trial lecture for the academic position of Associated Professor/Professor in Cariology and Gerodontology - "Recommended use of fluoride".
Aram Saeed is giving a talk on some of his latest work in the areas of Tissue Engineering, Biomaterials and Protein Delivery System.
Biomaterials hosts an open mini-seminar on the use of extracellular vesicles and platelet lysate in cell-free regenerative therapies and as cost-effective cell culture supplement.
On the occasion of Professor Karl Schenck's retirement, the faculty will host the symposium "Digital possibilities in research".
The Nansen Neuroscience Lectures (NNL) honour Nansen’s ground-breaking contribution to neuroscience and since 10.10.2010 are part of the Academy’s Nansen celebration. This year, Morten Scheibye-Knudsen, Center for Healthy Aging (CEHA), University of Copenhagen, will speak on "Discovering interventions for healthier, happier and more productive ageing".
Dr. Liliana Liverani will hold a seminar about the research activities at Institute of Biomaterials at Friedrich-Alexander-University Erlangen-Nuremberg. The seminar is free and open for all.
The UiO:Life Science ImmunoLingo Convergence Environment Symposium.
Professor Massimo Costalonga will give the lecture "Diagnostic and Prognostic Test for Periodontitis and Peri-implantitis"
Patent strategy is an important part of the innovation process. On this seminar you will hear from experts from Inven2 and learn how you can build a solid patent strategy.
The NO-Age Norwegian Centre on Healthy Ageing arranges its 2nd symposium on "Genomic instability in human brain".
Solid research is the basis for all new innovations. However, too often data generated in academia turns out to be irreproducible by others and therefor fail in translation to new products and treatments. What does it take to achieve reproducible high quality data?
The Department of Biomaterials hosts an open seminar on hierarchical and functional biomaterials based on protein self-assembly and nanocrystalline calcium phosphates.
Time and again, a product is being developed, approved, and launched, only to flop in the marketplace. So how can you get your ducks in a row to prepare for a successful product, and how early should you start this process? The answer: begin with the end in mind by creating and using a Target Product Profile (TPP).
Mini symposium will focus on the recent advances in diagnostics (including the Digital Oral Cancer Test) and management of potentially malignant oral disorders and oral cancers. The symposium is open for all and is being arranged in connection to a workshop for internationalization funded by UiO: Life Science.
National law and European directives, regulations and guidelines regulate development of medicinal product and medical devices. A product's successful journey from research to market and eventually patients requires a well-designed regulatory strategy and several consultations with regulatory authorities.
What are the most important skills you need to have as an entrepreneur and why is your business model just as important as your product?
We invite the citizens of Oslo to a light event with glimpses of life sciences at UiO and amazing ice sculptures.
At this seminar PhD students, postdocs and Master´s students in life sciences at UiO and NMBU had the opportunity to create networks outside academia. Watch videos and see pictures from the event.
Refreshments and mingling in Oslo City Hall for all participants of the conference. The Governing Mayor of Oslo, Raymond Johansen, is our host for the evening. You need a ticket to attend the reception. The reception is fully booked.
We highlighted inspiring examples on collaboration between academia and industry that have benefitted patients and society. How can we learn from these examples while building the health industry in Oslo and Norway?
Funding and partnering is critical when you want to commercialize an academic idea. What are the pitfalls? What is critical? What are the dos and don'ts?